161 related articles for article (PubMed ID: 38249970)
1. Hepatobiliary manifestations in patients with ulcerative colitis: a retrospective analysis.
Stratmann K; Aydolmus S; Gu W; Heling D; Spengler U; Terjung B; Strassburg CP; Vollenberg R; Blumenstein I; Trebicka J
Front Med (Lausanne); 2023; 10():1273797. PubMed ID: 38249970
[TBL] [Abstract][Full Text] [Related]
2. Liver biopsy in inflammatory bowel disease patients with sustained abnormal liver function tests: a retrospective single-center study.
Dias E; Andrade P; Lopes S; Gonçalves R; Cardoso P; Gaspar R; Cardoso H; Lopes J; Carneiro F; Macedo G
Ann Gastroenterol; 2023; 36(1):54-60. PubMed ID: 36593810
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
Navaneethan U; Remzi FH; Nutter B; Fazio VW; Shen B
Am J Gastroenterol; 2009 Oct; 104(10):2467-75. PubMed ID: 19550410
[TBL] [Abstract][Full Text] [Related]
4. Hepatobiliary manifestations in children with inflammatory bowel disease: A single-center experience in a low/middle income country.
El-Shabrawi MH; Tarek S; Abou-Zekri M; Meshaal S; Enayet A; Mogahed EA
World J Gastrointest Pharmacol Ther; 2020 Aug; 11(3):48-58. PubMed ID: 32844043
[TBL] [Abstract][Full Text] [Related]
5. Liver Function Test Abnormalities in Patients with Inflammatory Bowel Diseases: A Hospital-based Survey.
Cappello M; Randazzo C; Bravatà I; Licata A; Peralta S; Craxì A; Almasio PL
Clin Med Insights Gastroenterol; 2014; 7():25-31. PubMed ID: 24966712
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients.
Silva J; Brito BS; Silva INN; Nóbrega VG; da Silva MCSM; Gomes HDN; Fortes FM; Pimentel AM; Mota J; Almeida N; Surlo VC; Lyra A; Rocha R; Santana GO
Biomed Res Int; 2019; 2019():7604939. PubMed ID: 30834274
[TBL] [Abstract][Full Text] [Related]
7. Colitis-associated sclerosing cholangitis in children: a single centre experience.
Noble-Jamieson G; Heuschkel RB; Torrente F; Hadzic N; Zilbauer M
J Crohns Colitis; 2013 Nov; 7(10):e414-8. PubMed ID: 23485432
[TBL] [Abstract][Full Text] [Related]
8. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
Rojas-Feria M; Castro M; Suárez E; Ampuero J; Romero-Gómez M
World J Gastroenterol; 2013 Nov; 19(42):7327-40. PubMed ID: 24259964
[TBL] [Abstract][Full Text] [Related]
9. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
10. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
Mazza S; Soro S; Verga MC; Elvo B; Ferretti F; Cereatti F; Drago A; Grassia R
World J Hepatol; 2021 Dec; 13(12):1828-1849. PubMed ID: 35069993
[TBL] [Abstract][Full Text] [Related]
11. Extraintestinal Manifestations in Children Diagnosed with Inflammatory Bowel Disease.
Kavcar Z; Civan HA; Taskin DG; Hatipoglu SS
Sisli Etfal Hastan Tip Bul; 2023; 57(1):73-78. PubMed ID: 37064841
[TBL] [Abstract][Full Text] [Related]
12. [Gut-liver axis in inflammatory bowel disease. A retrospective study].
Egresi A; Kovács Á; Szilvás Á; Blázovics A
Orv Hetil; 2017 Jul; 158(26):1014-1021. PubMed ID: 28651460
[TBL] [Abstract][Full Text] [Related]
13. The MYTHS of
James SD; Hawkins AT; Um JW; Ballard BR; Smoot DT; M'Koma AE
Jpn J Gastroenterol Hepatol; 2020; 3(2):. PubMed ID: 37584007
[TBL] [Abstract][Full Text] [Related]
14. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].
Mendoza JL; Lana R; Taxonera C; Alba C; Izquierdo S; Díaz-Rubio M
Med Clin (Barc); 2005 Sep; 125(8):297-300. PubMed ID: 16159555
[TBL] [Abstract][Full Text] [Related]
15. Hepatobiliary disorders among naïve patients with ulcerative colitis in Upper Egypt.
Morsy KH; Hasanain AF
Arab J Gastroenterol; 2012 Jun; 13(2):71-6. PubMed ID: 22980595
[TBL] [Abstract][Full Text] [Related]
16. Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease.
Heikius B; Niemelä S; Lehtola J; Karttunen T; Lähde S
Scand J Gastroenterol; 1997 Feb; 32(2):153-61. PubMed ID: 9051876
[TBL] [Abstract][Full Text] [Related]
17. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
18. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
19. Liver Pathology in Children with Diagnosed Inflammatory Bowel Disease-A Single Center Experience.
Daniluk U; Kwiatek-Sredzinska K; Jakimiec P; Daniluk J; Czajkowska A; Lebensztejn DM
J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830641
[TBL] [Abstract][Full Text] [Related]
20. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.
Gizard E; Ford AC; Bronowicki JP; Peyrin-Biroulet L
Aliment Pharmacol Ther; 2014 Jul; 40(1):3-15. PubMed ID: 24815622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
